Health & Wellness

Alzheimer’s Enigma: New Insights Into An Old Foe

Event Date Mon Aug 19, 2019
Event Time 6 PM
The Sebastian – Vail16 Vail Road

Alzheimer’s disease will be one of the greatest public health challenges of the 21st century unless effective interventions are developed. As a result of increasing life expectancy in the Western world and developing countries, the number of elderly people at risk of developing Alzheimer’s disease is growing rapidly and is estimated to reach 115 million in 2050. The oldest, those older than 85, comprise the fastest growing segment of the population with more than 50% suffering from Alzheimer’s disease. It’s now a public health imperative to find pragmatic solutions for the disease and end the suffering of the patients and their families.
Dr. Michal Beeri will discuss how the disease is diagnosed, what are considered “concerning” and “non concerning” memory problems, risk and protective factors for the disease, whether genetics affect the risk of developing Alzheimer’s disease, why the medications we are investigating are not working, the new therapeutic directions the field is taking and how novel technologies may help prevent the disease altogether. Following Dr. Beeri’s presentation, Dr. Samantha Holden of the CU School of Medicine will engage Dr. Beeri in a dialogue exploring the status of the fight against Alzheimer’s.

This program is generously underwritten by Dierdra & Ronnie Baker and Bobbie & Jim Ruh. It is sponsored by Vail Health and produced in partnership with B’nai Vail

Event SPEAKER(S)

Prof. Michal Beeri

Prof. Michal Beeri

Director of the Joseph Sagol Neuroscience Center

Sheba Medical School, Israel

Dr. Samantha Holden

Dr. Samantha Holden

Assistant Professor of Neurology

CU School of Medicine